The new Reference Standard allows laboratories and assay developers to optimize, validate and routinely monitor performance of polymerase chain reaction (PCR)-based tests, next generation sequencing ...
People with EGFR mutation-positive NSCLC whose tumours have been surgically ... The most likely cost-effectiveness estimates are within the range that NICE normally considers an acceptable use of NHS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback